Terbium-161 PSMA Therapy for Prostate Cancer | Minute Medical, Vienna

While much of the oncological world remains focused on traditional isotopes, Minute Medical in Vienna has moved to the next generation of radionuclide therapy with Terbium-161 (Tb-161) PSMA therapy. This transition represents a significant leap forward in the field of "Theranostics". Terbium-161 is often described as the "enhanced sibling" of Lutetium-177 because it provides a more comprehensive radiation profile. At our boutique clinic, located in the heart of Austria’s medical district, we utilize this rare isotope to target metastatic prostate cancer with a level of sub-cellular intensity that was previously unreachable. The biological advantage of Terbium-161 lies in its "triple-emission" energy spectrum. Unlike standard isotopes, which primarily emit beta particles, Terbium-161 also emits a high density of Auger and conversion electrons. This is a critical distinction because while beta particles travel several millimeters to treat larger tumor masses, Auger electrons travel a distance shorter than the diameter of a single cell. This means that once the PSMA-targeting molecule docks onto the cancer cell, the Terbium payload releases a massive burst of energy directly into the cell’s nucleus. This localized "energy dump" is specifically designed to eradicate micrometastases, the tiny, invisible clusters of cancer cells that often survive standard treatments and lead to future recurrence. At Minute Medical, we integrate this high-physics approach into a refined clinical experience. The process begins with a high-resolution 68Ga-PSMA PET/CT to map the "target landscape" of the disease. Only when we have visualized the exact location and intensity of the PSMA expression do we proceed with the Terbium-161 infusion. The treatment itself is administered intravenously in our private, modern suites, which are designed to feel more like a first-class lounge than a hospital ward. Because Terbium-161 delivers a higher "absorbed dose" to the tumor than to healthy tissue, our patients benefit from a superior therapeutic index, meaning more of the radiation reaches the cancer with less impact on the rest of the body. Patient safety and comfort are maintained through a sophisticated "Organ Protection Protocol" unique to the Minute Medical experience. During the infusion, we use specialized cooling techniques for the salivary glands and intensive amino-acid hydration to shield the kidneys from radiation. Our nuclear medicine specialists, who are among the few in Europe experienced with this specific isotope, provide continuous monitoring throughout the short outpatient stay. This allows international patients to receive the most advanced molecular therapy available today and return to their hotel in Vienna the same afternoon, avoiding the stress of overnight hospitalization. The commitment to Terbium-161 at Minute Medical is to leave no cancer cell behind. By harnessing the unique Auger-electron effect, we provide a sophisticated solution for patients with complex metastatic profiles or those who have shown resistance to earlier lines of therapy. Our goal is to provide the absolute cutting edge of nuclear medicine in an environment that prioritizes the patient’s dignity, time, and long-term quality of life. Through the precision of Terbium-161, we are not just treating the cancer of today; we are targeting the potential recurrence of tomorrow.